InvestSMART

ALS Limited (ASX: ALQ) - ETF Exposure

Current share price for ALQ : $22.360 0.63 (2.74%)+

ALS Limited (ALQ) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It provides comprehensive testing solutions to clients in a wide range of industries around the world. Using advanced technologies and innovative methodologies, the Company's international teams deliver testing services and personalised solutions, leveraging local expertise to drive data-driven insights for a safer, healthier world.

ALQ General Information +

ASX Code ALQ
Website http://alsglobal.com
Industry/Sector Research & Consulting Services
Market Cap ($M) 11,348
ALQ Share Price $22.360
Day High $23.460
Day Low $22.310
Last Close $22.990
ALQ Share Price Movement $0.63 ( 2.74% )
Prices as at 16:35, 14 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to ALQ

As one of Australia's largest companies by market capitalisation, ALQ is held across 36 ETFs spanning strategies that include research & consulting services exposure . Its weighting in those funds means performance can have an outsized influence - when ALQ moves, funds like M1DS, VSO, ALFA, VNGS and MTUM that hold it can move with it.

For more concentrated exposure, ETFs such as M1DS (Paradice Australian Mid Cap Fund Active ETF) allocate about 6.2% to ALQ , while the average exposure across all 36 ETFs that hold it is around 1% .

Top ETF holdings

Last updated: ETF data and holdings as at 13 August 2026

Own ALQ directly or through an ETF?

How does holding ALS Limited (ALQ) shares directly compare to ETFs that include it?

ALQ Direct
M1DS
CBOE
VSO
ASX
ALFA
ASX
VNGS
ASX
MTUM
ASX
Holdings 1 company 51 holdings 193 holdings 70 holdings 54 holdings 89 holdings
ALQ Weight 100% 6.2% 2.2% 2.1% 2% 1.8%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only - 0.3% p.a. 0.39% p.a. 1.12% p.a. 0.35% p.a.
Approx. Yield 2% - 4.63% 0.88% 1.62% 2.17%
Star Ratings - star starstarstarstar star star starstarstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not ALQ's direct yield. Annual cost uses each ETF's MER.

ALQ Exposure on $10,000 investment

How a $10,000 investment in ALS Limited (ALQ) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
ALS Limited (ALQ) Direct share $22.360 -4.89% -$489 $9,511
Paradice Australian Mid Cap Fund Active ETF (M1DS) Equity - Australia Strategy $6.470 3.19% +$319 $10,319
Vanguard MSCI Australian Small Companies Index ETF (VSO) Equity - Australia Small/Mid Cap $75.420 0.21% +$21 $10,021
Vaneck Australian Long Short Complex ETF (ALFA) Equity - Australia Strategy $22.780 -1.64% -$164 $9,836
Vaughan Nelson Global SMID Fund (Managed Fund) (VNGS) Equity - Global Strategy $3.960 1.54% +$154 $10,154
Betashares Australian Momentum ETF (MTUM) Equity - Australia Strategy $27.990 -0.74% -$74 $9,926

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

ALS Limited (ALQ) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 23.1¢ 30% 12 Jun 2026 3 Jul 2026 - - -
Result 19.4¢ 29.90% 26 Nov 2025 17 Dec 2025 - - -
HFResult 19.7¢ 30% 3 Jul 2025 25 Jul 2025 - - -

See all dividends from ALS Limited (ALQ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

ALS Limited (ALQ) price-sensitive announcements

ALQ - CEO address to shareholders and trading update
ALS Limited's CEO addressed shareholders at the 2026 Annual General Meeting, highlighting
ALS Limited (ALQ)
28 Jul 2026 | 8:54 AM
ALQ - S&P DJI Announces June 2026 Quarterly Rebalance
S&P Dow Jones Indices announced the June 2026 quarterly rebalance of the S&P/ASX Indices,
ALS Limited (ALQ)
5 Jun 2026 | 5:12 PM
ALQ - ALS Full Year Results Investor Presentation
ALS Limited reported robust financial results for FY26, showcasing a 10.7% increase in rev
ALS Limited (ALQ)
18 May 2026 | 8:24 AM
ALQ - ALS Full Year results
ALS Limited achieved a record financial performance in FY26, with a 10.7% increase in reve
ALS Limited (ALQ)
18 May 2026 | 8:23 AM

ALS Limited (ALQ) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Change of Director's Interest Notice 14 Aug 2026 8:16AM $22.990 $22.360 fallen by 2.74%
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Change of Director's Interest Notice 5 Aug 2026 10:46AM $22.660 $22.360 fallen by 1.32%
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Change of Director's Interest Notice 3 Aug 2026 10:25AM $21.760 $22.360 risen by 2.76%
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Notification regarding unquoted securities - ALQ 3 Aug 2026 10:22AM $21.760 $22.360 risen by 2.76%
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Final Director's Interest Notice 29 Jul 2026 9:47AM $21.820 $22.360 risen by 2.47%
ALS Limited (ALQ)
ORDINARY FULLY PAID
Industrials $11,349 Retirement of Director 29 Jul 2026 9:45AM $21.820 $22.360 risen by 2.47%

ALQ Financial Summary

Year to Mar NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $342.85 $70.81 16.40% 23.64 42.49 2.54% 19.9%
2025F $294.47 $60.82 -0.70% 27.52 36.49 2.18% 19.9%
2024A $296.50 $61.24 -3.70% 19.60 39.20 3.27% 20.0%

ALQ Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
ALS Limited (ALQ) $11,887M 0.2288 0.1710 0.1198 30.4948 26.0425 23.2572 1.81% 2.21% 2.47%
IPH Limited (IPH) $1,084M -0.0218 0.4799 0.0242 13.0798 8.8383 8.6291 8.63% 9.05% 9.27%

ALQ Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.80 28.10 6.86 1.94
Market 0.61 17.90 1.65 1.06
Sector 0.66 19.40 2.48 1.60

ALQ Directors

Name Position Start Date
Mr Malcom Deane Chief Strategy Officer, General Manager, Life Sciences - Food & Pharma Americas, General, Chief Executive Officer, Managing Director 7 Mar 2023
Ms Christina (Christy) Boyce Non-Executive Director 1 Sep 2025
Ms Leslie A Desjardins Non-Executive Director 21 Nov 2019
Dr Siddhartha Kadia Non-Executive Director 15 Jan 2019
Ms Erica Mann Non-Executive Director 1 Mar 2024
Mr Peter Possemiers Non-Executive Director 1 Nov 2022
Ms Catharine Farrow Non-Executive Director 24 Mar 2025
Mr Nigel David Garrard Non-Executive Director, Non-Executive Chairman 7 Jun 2023

ALS Limited (ALQ) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
30 Jul 2026 DEANE, Malcom Sell Direct Shares 60,944 $21.087 $1,285,097.080
29 May 2026 FARROW, Catharine Buy Direct Shares 4,200 $23.911 $100,425.360
27 May 2026 DESJARDINS, Leslie Buy Direct Shares 1,200 $23.583 $28,300.100

See all changes in directors' interest & trades for ALS Limited (ALQ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ALQ Management

Name Position
Stuart Hutton Chief Financial Officer
Dayna Field Company Secretary,General Counsel

ALQ Calendar of Events

Date Event
25 June 2027 Report (Annual)
17 May 2027 Report (Prelim)
17 November 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.